RTN4 · Western blot design guide

RTN4 Western Blot Planning Guide

Plan a RTN4 Western blot around the catalog-observed 129.9 kDa band, image-backed A01844-2 evidence, HPA controls, and verified protocol records.

Evidence assembled July 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for RTN4 (RTN4): expected band 129.9 kDa, antibody A01844-2, and guide-derived SDS-PAGE protocol steps
RTN4 Western blot protocol sheet — expected band 129.9 kDa, antibody A01844-2, controls and PMC citations. Open the full RTN4 WB guide →

RTN4 Western Blot Experimental Design Guide

Expected bands, documented protocol parameters, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band 129.9 kDa
Observed band Not reported — verify product WB image
Gel 8-10%
Positive control ⓘ Cerebellum
Negative control ⓘ Appendix
Important caveats
Reasons your observed band may differ from the expected size.
ⓘ Calculated mass 129.9 kDa
ⓘ Localization Endoplasmic reticulum membrane / Cell membrane
ⓘ Processing / PTM Record-dependent
ⓘ Reactivity Human
Section 1

Real Curated RTN4 Western Blot Protocols

Start with the molecular-weight rule, then compare verified publication-derived conditions.

Recommended Western blot protocol parameters
Sample / lysateCaudate
Gel %8-10%
Load20-30 µg total protein per lane
TransferWet/tank, extended transfer
Membrane0.45 µm PVDF
Blocking5% non-fat milk or 5% BSA in TBST
PrimaryA01844-2 at datasheet starting dilution
Primary incubationOvernight at 4 °C with gentle agitation
SecondarySpecies-matched HRP conjugate at validated dilution
Wash3 × 5 min in TBST
DetectionChemiluminescent substrate
ExposureBracket exposures to avoid saturation
Section 2

What Is the Expected RTN4 Western Blot Band Size?

Use the product-observed 129.9 kDa band as the primary planning value and retain the UniProt calculated mass as context.

What am I looking at on my blot?
129.9 kDaMatches the authoritative product WB observation.
129.9 kDa calculatedUse as UniProt context, not as a replacement observed band.
Unexpected additional signalDo not assign identity without orthogonal positive/negative controls.
💡Expected RTN4 appearancePlan around 129.9 kDa and keep the calculated mass as supporting context.
How each factor affects band size
Catalog-observed band129.9 kDa; use this as the primary experimental expectation.
Calculated mass129.9 kDa from UniProt Q9NQC3; retain as context.
Gel selection8-10%; shared with the recommended protocol and poster.
Specificity checkCompare the lead HPA positive and negative controls with A01844-2.
Why is my band missing or off?
SituationLikely causeNext action
129.9 kDaMatches the authoritative product WB observation.Confirm with orthogonal controls and the linked product record.
Additional bandMay reflect processing, modification, or non-specific signal.Run a dilution series and compare positive/negative controls.
Weak signalTarget abundance or transfer may be limiting.Verify transfer, increase positive-control abundance, and bracket exposure.

Sample controls for RTN4 Western blot

🧪Use Cerebellum as the first positive-control candidate and Appendix as the HPA Not detected negative candidate.
Positive control: Cerebellum (High)
Negative control: Appendix (Not detected)
HPA protein score determines control status; other expression data is supporting context only.

HPA tissue expression evidence for RTN4

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Positive expression · recommended positive controls

TissueCell typeLevelEvidenceSource
Cerebellum Reported tissue cells High Protein (HPA) HPA →
Caudate Reported tissue cells High Protein (HPA) HPA →
Testis Reported tissue cells High Protein (HPA) HPA →
Hippocampus Reported tissue cells Medium Protein (HPA) HPA →

Undetected expression · recommended negative controls

TissueCell typeLevelEvidenceSource
Appendix Reported tissue cells Not detected Protein (HPA) HPA →
Bone marrow Reported tissue cells Not detected Protein (HPA) HPA →
Section 3

Advanced RTN4 Western Blot Tips

Deeper troubleshooting and optimisation questions for RTN4, answered from its protein features.

Which band should guide the blot?
Use 129.9 kDa, the observation attached to the authoritative A01844-2 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 129.9 kDa expectation.
Which positive control should I start with?
Start with Cerebellum, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use Appendix as an orthogonal HPA Not detected candidate.
Which gel should I use?
Use 8-10% consistently across the quick facts, protocol table, and poster.
What transfer method to use for RTN4 Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should A01844-2 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
No verified publication protocol was supplied; use only the deterministic recommended protocol.
Boster reagents

RTN4 Western Blot Reagents

Human-reactive RTN4 Western blot reagents with authoritative product imagery.

Real WB data Western blot validation image for RTN4 using A01844-2; observed band 129.9 kDa
Anti-Nogo A/RTN4 Antibody Picoband®
Cat # A01844-2

Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.

Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.

References

  1. UniProt Q9NQC3
  2. Human Protein Atlas — RTN4
  3. A01844-2 product record
  4. PMC13141869 — Nrf2 regulates angiogenesis in spinal cystic echinococcosis via RTN4 (Microbiology spectrum, 2026)
  5. PMC12041605 — The assembly of RAB22A/TMEM33/RTN4 initiates a secretory ER-phagy pathway (Cell discovery, 2025)